Daxor (DXR) News Today $8.10 +0.04 (+0.50%) As of 03:06 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Daxor (NASDAQ:DXR) Price Target Raised to $25.00 at Ascendiant Capital MarketsMarch 18, 2025 | americanbankingnews.comDaxor Co. (NASDAQ:DXR) CEO Buys $25,804.80 in StockMarch 12, 2025 | insidertrades.comDaxor Corporation (NASDAQ:DXR) Q4 2024 Earnings Call TranscriptMarch 10, 2025 | msn.comEarnings call transcript: Daxor Q4 2024 sees 116.5% revenue growthMarch 8, 2025 | investing.comDaxor Corporation (DXR) Q4 2024 Earnings Call TranscriptMarch 6, 2025 | seekingalpha.comDaxor Corporation Reports Increase in NAV to $7.25 Per Share and 116.5 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2024March 4, 2025 | globenewswire.comDaxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025March 4, 2025 | globenewswire.comDaxor reports increase in NAV to $7.25 per shareMarch 4, 2025 | markets.businessinsider.comDaxor issues letter to shareholdersMarch 4, 2025 | markets.businessinsider.comDaxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to ShareholdersMarch 4, 2025 | globenewswire.comDaxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to ShareholdersMarch 4, 2025 | globenewswire.comDaxor Corporation Reports Increase in NAV to $7.25 Per Share and 116.5 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023March 4, 2025 | globenewswire.comDaxor Expands Blood Volume Analysis Services at Major Midwest Healthcare CenterFebruary 28, 2025 | globenewswire.comDaxor expands blood volume analysis technology to New Jersey hospitalsFebruary 27, 2025 | markets.businessinsider.comDaxor Corporation Expands Blood Volume Analysis Technology to Major New Jersey HospitalsFebruary 27, 2025 | globenewswire.comDaxor Corporation Announces New Data on Blood Volume Analysis from Duke and Yale Universities Presented at THT 2025February 19, 2025 | globenewswire.comTruLite Health Bolsters Health Equity Expertise with Expanded Leadership TeamFebruary 18, 2025 | businesswire.comDaxor to Exhibit at World's Largest Critical Care ConferenceFebruary 18, 2025 | globenewswire.comDaxor's Blood Volume Analysis Uncovers Hidden Heart Failure Subtype in Nearly 1 in 5 Patients, Enabling Targeted TreatmentFebruary 14, 2025 | globenewswire.comNew Multicenter Study Highlights Utility of Daxor’s Blood Volume Analysis in Heart Failure CareFebruary 13, 2025 | markets.businessinsider.comDaxor Hikeson Blood StudyFebruary 13, 2025 | baystreet.caDaxor announces study published on its Blood Volume AnalysisFebruary 13, 2025 | markets.businessinsider.comNew Multicenter Study Highlights Utility of Daxor's Blood Volume Analysis in Heart Failure CareFebruary 13, 2025 | globenewswire.comDaxor Expands Its BVA-100™ Blood Volume Diagnostic to Two New Hospital Systems Adding to Sales MomentumDecember 18, 2024 | globenewswire.comDaxor Corporation Common Stock (DXR) SEC FilingsDecember 14, 2024 | nasdaq.comDAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24October 9, 2024 | globenewswire.comDaxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual SummitOctober 8, 2024 | globenewswire.comDaxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic DeviceSeptember 27, 2024 | globenewswire.comDaxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024September 19, 2024 | globenewswire.comLeading Central Florida Hospital Implements Daxor's BVA-100™ Blood Volume Diagnostic for Heart Failure Patient CareSeptember 4, 2024 | globenewswire.comDaxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder LetterSeptember 3, 2024 | globenewswire.comDaxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 3, 2024 | globenewswire.comDaxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated NetworkAugust 29, 2024 | globenewswire.comDaxor Expands To Three New Facilities As Blood Volume Analysis Technology Gains Momentum NationwideAugust 5, 2024 | globenewswire.comDaxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual MeetingJune 18, 2024 | globenewswire.comDaxor Corporation Announces New Hospital Account at Leading Chicago HospitalApril 10, 2024 | globenewswire.comDaxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of DiagnosticsMarch 25, 2024 | globenewswire.comDaxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024March 22, 2024 | globenewswire.comDaxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023March 18, 2024 | globenewswire.comDaxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to ShareholdersMarch 18, 2024 | globenewswire.comDaxor Announces Sales to Three New Hospitals Furthering Expansion of Its User BaseMarch 11, 2024 | globenewswire.comMulti-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor's Unique Clinical Utility for Heart Failure PatientsMarch 8, 2024 | globenewswire.comDaxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics ConferenceFebruary 26, 2024 | globenewswire.com Remove Ads Get Daxor News Delivered to You Automatically Sign up to receive the latest news and ratings for DXR and its competitors with MarketBeat's FREE daily newsletter. Email Address DXR Media Mentions By Week DXR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DXR News Sentiment▼1.440.78▲Average Medical News Sentiment DXR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DXR Articles This Week▼20▲DXR Articles Average Week Remove Ads Get Daxor News Delivered to You Automatically Sign up to receive the latest news and ratings for DXR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Pro-Dex News TriSalus Life Sciences News Orchestra BioMed News Beauty Health News Neuronetics News Sight Sciences News KORU Medical Systems News Jin Medical International News Monogram Orthopaedics News InfuSystem News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DXR) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daxor Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Daxor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
